Özge Akbulut-Çalışkan
6PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 15, 2025
HER2-targeted therapy in colorectal cancer: a comprehensive review.Yeliz Benli, Helin Arıkan, Özge Akbulut-Çalışkan
|Feb 06, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.Mustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer
|Mar 02, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.Ozge Saatci, Ozge Akbulut, Metin Cetin
|Oct 31, 2021
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers.Esra Cicek, Ayca Circir, Merve Oyken
|May 17, 2020
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.Ozge Saatci, Aysegul Kaymak, Umar Raza
|Mar 29, 2020
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.Ozge Akbulut, Deniz Lengerli, Ozge Saatci
Pageof 1
Frequent Collaborators
5 joint publications
Ozgur Sahin
2 joint publications
Aynur Isik
2 joint publications
Erden Banoglu
2 joint publications
Ozge Saatci
2 joint publications
Aysegul Uner
2 joint publications
Sercan Aksoy
1 joint publications
Helin Arıkan
1 joint publications
Urartu O S Seker
1 joint publications
Aytekin Akyol
1 joint publications
Pelin G Ersan
